Search results :

Desonide

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Codes: D07AB08, S01BA11

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10
Infection Infection 19.6% - 20.4% x
Secondary infection x x x x x x x x x x
Infestation Infestation NOS 19.6% - 20.4% x
Upper respiratory tract infection Upper respiratory tract infection 6.19% - 9.56% x x
Mediastinal disorder Mediastinal disorder 3.61% - 6.98% x
Application site pain Application site burn 2.84% - 7.73% x x x x
Application site burn Application site burn 2.84% - 7.73% x x x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue 2.58% - 3.09% x
Cough Cough 1.55% - 3.62% x x
Hyperglycaemia Hyperglycaemia 2% x x
Application site reaction Application site reaction 0.775% - 3.09% x
Skin striae Skin striae 0.775% - 3.09% x x x x x x x x x x
Atrophy Atrophy 0.775% - 3.09% x
Headache Headache 0.515% - 1.81% x x x x
Nervous system disorder Nervous system disorder 0.515% - 1.81% x
Blood pressure increased Blood pressure increased 0.515% - 1.55% x x
Dermatitis contact Dermatitis contact 0.775% - 1.03% x x x x
Allergic contact dermatitis x x x x x
Viral infection Viral infection 0% - 1.55% x x
Telangiectasia Telangiectasia 0% - 3.09% x x x x
Application site atrophy Application site atrophy 0% - 1.29% x x
Pharyngitis streptococcal Pharyngitis streptococcal 0.515% - 0.517% x
Application site rash Application site rash 0.515% - 0.517% x
Asthma Asthma 0% - 0.775% x x
Mental disorder Mental disorder 0% - 0.775% x
Irritability Irritability 0% - 0.517% x x
Pharyngitis Pharyngitis 0% - 0.517% x x
Swelling face Swelling face postmarketing x
Application site irritation Application site irritation postmarketing x
Application site erythema Application site erythema postmarketing x
Dermatitis Rash x x x x
Dermatitis perioral x x x x x x x x x x
Rash Rash x x x x
Folliculitis Folliculitis x x x x x x x x x x
Miliaria Miliaria x x x x x x x x x x
Pain Pain x x
Stinging x x x
Pruritus Pruritus x x x x x x
Hyperhidrosis Sweating x x
Erythema Erythema x x x x x x
Rash pustular Rash pustular x x
Oedema peripheral Oedema peripheral x x x
Skin atrophy Skin atrophy x x x x x x x x
Leukoderma Leukoderma x x x x x x x x x x
Dermatitis acneiform Acneiform eruption x x x x x x x x x x
Skin exfoliation Skin exfoliation x x x
Induration Induration x x
Application site pruritus Application site pruritus x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

desonide

Side effects:13
Source:FDA Structured Product Label

DESONIDE

Side effects:13
Source:FDA Structured Product Label

Desonide

Side effects:13
Source:FDA Structured Product Label

desonide

Side effects:13
Source:FDA Structured Product Label

DESONIDE

Side effects:13
Source:FDA Structured Product Label

DESONIDE

Side effects:13
Source:FDA Structured Product Label

DESONIDE

Side effects:17
Source:FDA Structured Product Label

Desonide

Side effects:18
Source:FDA Structured Product Label

DESONIDE

Side effects:23
Source:FDA Structured Product Label

DESONIDE / VERDESO

Side effects:29
Source:FDA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label